Mode
Text Size
Log in / Sign up

Predictive nomogram with spectral CT radiomics and deep learning features improves preoperative STAS prediction in surgically resected lung adenocarcinoma.

Predictive nomogram with spectral CT radiomics and deep learning features improves preoperative STAS…
Photo by Logan Voss / Unsplash
Key Takeaway
Consider a nomogram combining spectral CT radiomics and deep learning for preoperative STAS prediction in lung adenocarcinoma.

This retrospective cohort study assessed a predictive nomogram designed to estimate the presence of subpleural invasion (STAS) in patients with surgically resected lung adenocarcinoma. The analysis included 197 patients and compared a composite model against alternative approaches using only radiomics features, only deep learning features, or a combination of both without clinical characteristics.

The composite nomogram, which integrated spectral dual-layer detector CT radiomics, deep learning features, and pleural indentation, achieved an area under the curve (AUC) of 0.918 in the training cohort and 0.896 in the testing cohort. In comparison, the deep learning radiomics model yielded AUCs of 0.904 and 0.862, respectively, indicating superior performance for the integrated approach.

No adverse events, serious adverse events, discontinuations, or tolerability issues were reported, as this was a diagnostic modeling study rather than a therapeutic trial. Key limitations include the absence of reported p-values or confidence intervals for the AUC differences and the lack of details regarding the specific deep learning architectures or feature extraction methods used.

While the authors note the tool may serve as a valuable aid for devising personalized surgical treatments, the observational nature of the data prevents causal conclusions. The model requires external validation in diverse populations before it can be considered for routine clinical decision-making regarding surgical resection strategies.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveTumor spread through air spaces (STAS) is associated with increased lung adenocarcinoma recurrence, but it can only be identified postoperatively. Here, a predictive nomogram for detecting preoperative STAS was devised, by combining clinical characteristics with spectral dual-layer detector CT (SDCT)-extracted radiomics (Rad) and deep learning (DL) features.MethodsA total of 197 surgically resected lung adenocarcinoma patients were divided randomly into training (137) and testing (60) cohorts; clinical data, SDCT images, and tumor tissue samples for histopathological STAS identification were obtained. Rad features were extracted by PyRadiomics, and DL by the ResNet50 convolutional neural network, from manually delineated tumor regions of interest in SDCT, and then incorporated into seven machine learning algorithms; receiver operating characteristic (ROC) analysis identified the best-performing one for the Rad, DL, and DLR (Rad+DL) models. The predictive nomogram was formed by combining DLR with statistically significant clinical characteristics identified by uni- and multivariate logistic regression analyses, and its performance was evaluated by ROC and calibration curve analyses.ResultsLogistic regression was the best-performing machine learning algorithm, and DLR showed relatively better predictive performance than Rad and DL, with areas under the curve (AUCs) of 0.904 for the training and 0.862 for the testing cohort. The nomogram, comprising DLR with the clinical characteristic of pleural indentation, had the highest accuracy, with AUCs of 0.918 for the training and 0.896 for the testing cohort; its predictions strongly corresponded with actual STAS positivity under calibration curve analysis.ConclusionThe predictive nomogram facilitates reliable preoperative prediction of STAS in lung adenocarcinoma, serving as a valuable tool for devising personalized surgical treatments.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.